Most Viewed Articles
Articles | Fulltext downloads | PDF downloads | Total downloads |
---|---|---|---|
EditorialIndian Journal of Skin Allergy – Embracing new horizonsFull text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_39_2023 |
1,349 | 85,827 | 87,176 |
Review ArticleReactive and proactive treatment in atopic dermatitis: Long-term disease controlFull text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_31_2023 |
3,081 | 83,490 | 86,571 |
CommentaryStatus of research and publication in IndiaFull text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_29_2023 |
2,324 | 73,535 | 75,859 |
EditorialEczema and skin allergy-focus on researchFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_29_2024 |
1,387 | 60,474 | 61,861 |
Case ReportHair depigmentation in a patient treated with pazopanib: A case report and a comprehensive analysisFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_52_2023 |
2,997 | 44,153 | 47,150 |
Original ArticleEfficacy and safety of crisaborole ointment in pediatric atopic dermatitis: A 4-week open-label studyFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_45_2023 |
2,812 | 40,102 | 42,914 |
Letter to EditorMethotrexate in refractory chronic urticariaFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_15_2024 |
2,016 | 38,820 | 40,836 |
Case ReportAmbroxol-induced leukocytoclastic vasculitis: A case report and literature reviewFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_37_2023 |
2,322 | 37,082 | 39,404 |
Review ArticleCutaneous adverse drug reactions in children with a focus on hypersensitivity to systemic drugs: A narrative reviewFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_14_2024 |
1,296 | 35,333 | 36,629 |
Original ArticleComorbidities in patients with chronic urticaria: A cross sectional study from an Urticaria Center of Reference and ExcellenceFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_26_2023 |
3,404 | 24,506 | 27,910 |
SymposiumInvestigations and treatment of photodermatosesFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_6_2024 |
1,887 | 20,964 | 22,851 |
Case ReportA novel pitch against the itchFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_13_2024 |
2,737 | 18,834 | 21,571 |
Case ReportPembrolizumab-induced resolving papulosquamous eruption: An enigmatic presentation in a patient with renal cell carcinomaFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_3_2024 |
2,380 | 18,647 | 21,027 |
Review ArticlePigmented contact dermatitis: An updated reviewFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_44_2023 |
4,859 | 14,152 | 19,011 |
ImageGiant fixed drug eruptionFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_47_2023 |
2,279 | 13,965 | 16,244 |
Letter to EditorPost-herpetic neuralgia-associated patchy hair loss closely mimicking trichotillomaniaFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_19_2024 |
1,818 | 13,481 | 15,299 |
SymposiumPhototoxicity and photoallergy – A brief review on pathogenesis, recent advances, and approach to a patient with photosensitivityFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_9_2024 |
2,659 | 10,806 | 13,465 |
Original ArticleThe effectiveness of bilastine and fexofenadine updosing in the management of chronic spontaneous urticariaFull text![]() ![]() ![]() Year: 2022, Volume: 1, Issue: 2, July-December DOI: 10.25259/IJSA_3_2021 |
10,762 | 2,328 | 13,090 |
Letter to EditorDasatinib-induced hand foot syndrome followed by bosutinib-induced photoallergic contact dermatitis in a patient of chronic myeloid leukemia: A rare co-occurrenceFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_1_2024 |
1,683 | 11,349 | 13,032 |
Letter to EditorHomemade lip injection for cosmetic purpose: A case reportFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_42_2023 |
1,526 | 11,322 | 12,848 |
SymposiumCutaneous photobiologyFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_11_2024 |
2,407 | 9,036 | 11,443 |
Letter to EditorCutaneous vasculitis as the sole clinical feature of primary Sjögren’s syndromeFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_48_2023 |
2,420 | 8,863 | 11,283 |
Review ArticleA review of comorbidities in atopic dermatitisFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_37_2024 |
3,287 | 7,428 | 10,715 |
Original ArticleStudy of effectiveness of methotrexate oral pulse in refractory chronic urticariaFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_28_2023 |
2,239 | 8,440 | 10,679 |
Case ReportPenile angioedema in a child: A nightmare to parents!Full text![]() ![]() ![]() Year: 2022, Volume: 1, Issue: 1, January-June DOI: 10.25259/IJSA_5_2021 |
8,542 | 2,051 | 10,593 |
Resident’s CornerAllergic reactions to radiocontrast media–A brief overviewFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_4_2024 |
1,883 | 8,662 | 10,545 |
Letter to EditorHeat urticaria – Characterizing the population from an urticaria center of reference and excellence (UCARE)Full text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_51_2023 |
2,531 | 7,632 | 10,163 |
SymposiumPolymorphous light eruptionsFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_8_2024 |
1,815 | 8,210 | 10,025 |
Letter to EditorHot car seat thermal burn: A must sought for differential diagnosis in summersFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_31_2024 |
1,319 | 8,677 | 9,996 |
Original ArticleImpact of atopic dermatitis on quality of life in children and their families: A tertiary care hospital-based study from Northern IndiaFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_5_2024 |
2,637 | 7,292 | 9,929 |
Case ReportSubacute cutaneous lupus erythematosus in a patient of pancreatic cancer secondary to novel albumin-bound paclitaxel chemotherapyFull text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_25_2023 |
1,637 | 8,045 | 9,682 |
Review ArticleStem-cell therapy in dermatology – Challenges and opportunitiesFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_50_2023 |
3,732 | 5,921 | 9,653 |
Original ArticlePatch testing with Indian standard series of 20 allergens in 125 patients of chronic dermatitis and dermatosesFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_16_2024 |
3,680 | 5,870 | 9,550 |
CommentaryFellowship and mentorship opportunities in allergic skin disorders for Indian dermatologistsFull text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_30_2023 |
1,826 | 7,420 | 9,246 |
Original ArticleAtopic dermatitis in teenagers and adults: Clinical features of a tertiary referral hospitalFull text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_21_2022 |
1,651 | 7,230 | 8,881 |
SymposiumChronic actinic dermatitisFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_10_2024 |
1,895 | 6,783 | 8,678 |
Letter to EditorTeledermatology trends during two waves of the COVID-19 pandemic – Experience from western RajasthanFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_21_2024 |
1,377 | 7,095 | 8,472 |
Review ArticleJAK inhibitors in dermatologyFull text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 1, January-June DOI: 10.25259/IJSA_7_2021 |
6,215 | 2,225 | 8,440 |
Author’s replyPembrolizumab-induced resolving papulosquamous eruption: An enigmatic presentation in a patient with renal cell carcinomaFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_41_2024 |
1,365 | 6,986 | 8,351 |
Letter to EditorAre dermatologists a well-informed audience for artificial intelligence? A knowledge, attitude, and practice surveyFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_20_2024 |
1,619 | 4,825 | 6,444 |
Case ReportA rare case of diffuse penile phytocontact dermatitis caused by common greenbrierFull text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 1, January-June DOI: 10.25259/IJSA_22_2022 |
3,351 | 2,416 | 5,767 |
Case SeriesHand eczema associated with frequent hand washing and use of hand sanitizer during COVID-19 pandemic: A case seriesFull text![]() ![]() ![]() Year: 2022, Volume: 1, Issue: 2, July-December DOI: 10.25259/IJSA_11_2021 |
3,384 | 1,935 | 5,319 |
Review ArticleBiomarkers of chronic spontaneous urticariaFull text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_14_2023 |
3,613 | 1,611 | 5,224 |
Review ArticleChronic inducible urticaria: Clinical presentation, diagnosis, and managementFull text![]() ![]() ![]() Year: 2022, Volume: 1, Issue: 1, January-June DOI: 10.25259/IJSA_12_2021 |
3,534 | 1,511 | 5,045 |
Review ArticleDigital object identifier: What it is and why it matters?Full text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_20_2023 |
3,452 | 1,200 | 4,652 |
Letter to EditorVitamin D levels in patients with chronic spontaneous urticariaFull text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_3_2023 |
2,848 | 1,702 | 4,550 |
Letter to EditorSymmetrical drug-related intertriginous and flexural exanthema without baboon syndrome due to paracetamol: An uncommon side effect of a common drug: A case report and a review of literatureFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_30_2024 |
1,196 | 3,253 | 4,449 |
Letter to EditorComparative real-world clinical assessment of mometasone furoate 0.1% and fluticasone propionate 0.005% in the treatment of atopic dermatitisFull text![]() ![]() ![]() Year: 2022, Volume: 1, Issue: 2, July-December DOI: 10.25259/IJSA_4_2022 |
2,904 | 1,452 | 4,356 |
Letter to EditorExosome therapy in atopic dermatitis – A way to look forwardFull text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 1, January-June DOI: 10.25259/IJSA_26_2022 |
2,159 | 2,181 | 4,340 |
Letter to EditorInducible urticaria or skin lesions induced by Nd: YAG laser?Full text![]() ![]() ![]() Year: 2025, Volume: 4, Issue: 1, January-June DOI: 10.25259/IJSA_41_2023 |
1,411 | 2,889 | 4,300 |